Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Carcinoma × Vaccines × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Neoplasms 3 Breast Neoplasms 3 Papillomavirus Infections 2 Melanoma 2 Lung Neoplasms 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Sarcoma 1 Prostatic Neoplasms 1 Neuroblastoma 1 Neoplasms, Nerve Tissue 1 NY-ESO-1-expressing Tumors 1 Leukemia, Myeloid, Acute 1 Glioma 1 Diffuse Intrinsic Pontine Glioma 1 Condylomata Acuminata 1 Colonic Neoplasms 1 Carcinoma 1 Anus Neoplasms 1 Adenoviridae Infections 1 Adenocarcinoma 1

Interventions

Carboplatin 9 pembrolizumab 8 Paclitaxel 8 Cisplatin 8 Radiotherapy, Intensity-Modulated 6 Magnetic Resonance Spectroscopy 6 fludarabine 4 Specimen Handling 4 Pemetrexed 4 Nivolumab 4 Gemcitabine 4 Cyclophosphamide 4 trebananib 3 osimertinib 3 liposomal doxorubicin 3 Radiotherapy 3 Fluorouracil 3 Docetaxel 3 DNA 3 volociximab 2 poly ICLC 2 lenvatinib 2 fludarabine phosphate 2 Sorafenib 2 Radiosurgery 2 Midazolam 2 Interleukin-2 2 Capecitabine 2 Biopsy 2 Bevacizumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00684294 2020-03-02

Auto TAG

Mary Crowley Medical Research Center

Phase 1 Terminated

Carcinoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡